Axogen Inc
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porc… Read more
Axogen Inc (AXGN) - Total Liabilities
Latest total liabilities as of September 2025: $95.59 Million USD
Based on the latest financial reports, Axogen Inc (AXGN) has total liabilities worth $95.59 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Axogen Inc - Total Liabilities Trend (1986–2024)
This chart illustrates how Axogen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Axogen Inc Competitors by Total Liabilities
The table below lists competitors of Axogen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Torm PLC Class A
NASDAQ:TRMD
|
USA | $1.04 Billion |
|
JUSUNG ENGINEERING Co. Ltd
KQ:036930
|
Korea | ₩278.20 Billion |
|
Societatea Nationala de Transport Gaze Naturale Transgaz SA
RO:TGN
|
Romania | RON6.20 Billion |
|
CPFL Energia S.A
SA:CPFE3
|
Brazil | R$57.60 Billion |
|
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675
|
China | CN¥3.84 Billion |
|
Beijing YanDong MicroElectronic Co. Ltd. A
SHG:688172
|
China | CN¥4.51 Billion |
|
Shandong Humon Smelting Co Ltd
SHE:002237
|
China | CN¥21.20 Billion |
Liability Composition Analysis (1986–2024)
This chart breaks down Axogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Axogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Axogen Inc (1986–2024)
The table below shows the annual total liabilities of Axogen Inc from 1986 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $99.82 Million | -1.33% |
| 2023-12-31 | $101.16 Million | +7.18% |
| 2022-12-31 | $94.39 Million | -1.14% |
| 2021-12-31 | $95.47 Million | +22.04% |
| 2020-12-31 | $78.23 Million | +247.85% |
| 2019-12-31 | $22.49 Million | +70.50% |
| 2018-12-31 | $13.19 Million | -60.85% |
| 2017-12-31 | $33.69 Million | +7.17% |
| 2016-12-31 | $31.44 Million | +7.12% |
| 2015-12-31 | $29.35 Million | +6.16% |
| 2014-12-31 | $27.65 Million | +0.36% |
| 2013-12-31 | $27.55 Million | +19.46% |
| 2012-12-31 | $23.06 Million | +258.99% |
| 2011-12-31 | $6.42 Million | +5517.51% |
| 2010-12-31 | $114.35K | -98.01% |
| 2009-12-31 | $5.75 Million | +2623.10% |
| 2008-12-31 | $211.06K | +4.91% |
| 2007-12-31 | $201.17K | -7.66% |
| 2006-12-31 | $217.87K | +35.44% |
| 2005-12-31 | $160.86K | -69.13% |
| 2004-12-31 | $521.05K | -81.68% |
| 2003-12-31 | $2.84 Million | -10.65% |
| 2002-12-31 | $3.18 Million | +13.29% |
| 2001-12-31 | $2.81 Million | -25.16% |
| 2000-12-31 | $3.75 Million | +39.06% |
| 1999-12-31 | $2.70 Million | +22.73% |
| 1998-12-31 | $2.20 Million | -26.67% |
| 1997-12-31 | $3.00 Million | +114.29% |
| 1996-12-31 | $1.40 Million | -6.67% |
| 1995-12-31 | $1.50 Million | 0.00% |
| 1994-12-31 | $1.50 Million | -11.76% |
| 1993-12-31 | $1.70 Million | +142.86% |
| 1992-12-31 | $700.00K | 0.00% |
| 1991-12-31 | $700.00K | 0.00% |
| 1990-12-31 | $700.00K | -53.33% |
| 1989-12-31 | $1.50 Million | -97.09% |
| 1988-12-31 | $51.60 Million | +4590.91% |
| 1987-12-31 | $1.10 Million | -15.38% |
| 1986-12-31 | $1.30 Million | -- |